Health and Healthcare
59 Articles
Here are some of the top biotech names to buy at Cowen. They presented such an extensive list that we…
The analysts at Piper Jaffray have returned from meeting with some of the top biotechs the cover, and they have…
Piper Jaffray analyst have a list of top biotech stock picks that could bring big gains for investors. The look…
ThinkstockNektar Therapeutics (NASDAQ: NKTR) may have just burned a serious bridge for its future. The company is developing drugs for…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen so far this Tuesday. There is a…
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012…
It is now getting close to the middle of May, and that means one thing for biotech investors. The king…
The three major US equities indexes opened higher this morning after another (small) drop in new unemployment benefits claims and…
The three major US equities indexes opened higher this morning following a better-than-expected report on US GDP growth (our coverage…
Active traders and day traders have many stocks to choose from this Monday morning. We are tracking news and moves…
IMS Health (RX) Bad numbers and a downgrade. Falls to $21.20 from 52-week high of $33.12. The PMI Group (PMI)…
Nektar Therapeutics (NASDAQ:NKTR) is seeing shares hitting 52-week lows after its pharmaceutical partner Pfizer Inc. (NYSE:PFE) unexpectedly said it would…
Stock Tickers: ACA, AVAV, IDIX, KERX, NKTR, REDE, STAA, TRMP, UBET, WON The DJIA & S&P 500 Index may have…
Hovnanian (HOV) House of pain for home builders. Down to $17.36 from 52-week high of $36.66. Pulte Homes (PHM) More…
Our top personal finance-related articles today. Your wallet will thank you later.